ABVC BioPharma, Inc.
ABVC
$1.00
-$0.06-5.74%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -736.90K | -1.56M | -3.56M | -1.25M | -2.26M |
| Total Depreciation and Amortization | 89.50K | 92.20K | 214.00K | 96.00K | 80.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 203.40K | 690.30K | 2.00M | 1.18M | 1.65M |
| Change in Net Operating Assets | 199.60K | -116.40K | -71.90K | -158.20K | -365.90K |
| Cash from Operations | -244.40K | -894.20K | -1.42M | -133.30K | -894.20K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -101.50K | 47.10K | 730.30K | -1.27M | -665.80K |
| Cash from Investing | -101.50K | 47.10K | 730.30K | -1.27M | -665.80K |
| Total Debt Issued | 153.80K | -- | 730.00K | 150.00K | 9.00K |
| Total Debt Repaid | -29.60K | -661.70K | -108.70K | -335.70K | -74.10K |
| Issuance of Common Stock | 0.00 | 421.50K | 528.20K | 1.32M | 2.04M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 102.00K | -102.00K | -- | -- | -46.30K |
| Cash from Financing | 226.20K | -342.20K | 1.15M | 1.13M | 1.93M |
| Foreign Exchange rate Adjustments | 11.40K | 2.60K | 12.20K | 51.80K | -50.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -108.40K | -1.19M | 473.10K | -222.40K | 316.80K |